TUMT Procedure: Transurethral Microwave Thermotherapy for BPH – Complete Guide
- What is TUMT?
- How does TUMT work?
- Who is a good candidate for TUMT?
- The TUMT procedure – what to expect
- Recovery and downtime
- Effectiveness – symptom improvement and durability
- Side effects – retrograde ejaculation, dysuria, hematuria
- TUMT vs. TURP vs. Rezum vs. UroLift
- Cost and insurance coverage
- Why TUMT is less common today
- Interactive FAQ – 9 questions about TUMT
What is TUMT?
Transurethral Microwave Thermotherapy (TUMT) is a minimally invasive treatment for benign prostatic hyperplasia (BPH) that uses microwave energy to heat and destroy excess prostate tissue. It was one of the first MISTs developed and has been available since the 1990s.
TUMT is performed as an outpatient procedure under sedation. It is less invasive than TURP but has been largely replaced by newer technologies like Rezum and UroLift, which offer better outcomes with fewer side effects.
How does TUMT work?
TUMT works by delivering microwave energy to heat and destroy prostate tissue:
The mechanism:
- A microwave antenna is inserted through the urethra into the prostate
- The antenna emits microwave energy, heating the prostate to 55-70°C (131-158°F)
- A cooling catheter circulates water through the urethra to protect the urethral lining from thermal damage
- The heat causes coagulative necrosis (cell death) in the prostate tissue
- Dead tissue is absorbed by the body over 4-12 weeks
- The prostate shrinks, relieving urethral obstruction
Key features:
- No incisions
- Cooling system protects the urethra
- Single treatment session
- No implants left behind
Who is a good candidate for TUMT?
Ideal candidates for TUMT meet the following criteria:
- Prostate size: 30-80 mL (small to moderately enlarged)
- Symptoms: Moderate to severe BPH symptoms (IPSS ≥12)
- Medication failure: Poor response or intolerance to BPH medications
- Not a candidate for or does not want surgery (TURP)
- Acceptable risk of retrograde ejaculation (20-30% rate)
Who is NOT a good candidate?
- Very large prostates >80 mL (less effective)
- Active urinary tract infection
- Bladder stones
- Urethral stricture (narrowing) that prevents scope passage
- Known prostate cancer (requires different treatment)
- Pacemaker or implanted metal device (contraindication for microwave)
The TUMT procedure – what to expect
Before the procedure:
- Stop blood thinners (if possible – discuss with your doctor)
- Antibiotics may be prescribed to prevent infection
- No special bowel preparation required
Day of procedure:
- Performed in a urology office, outpatient centre, or hospital
- Anaesthesia: Intravenous sedation (not general anaesthesia) – you are asleep but breathing on your own
- Position: Lying on your back with legs in stirrups
- Duration: 30-60 minutes
Step-by-step:
- A small scope with a microwave antenna is inserted into the urethra
- A cooling catheter is placed to protect the urethral lining
- The microwave antenna is positioned within the prostate
- Microwave energy is delivered for 30-60 minutes
- Temperature sensors monitor prostate temperature (target 55-70°C)
- The scope and antenna are removed
- A urinary catheter is placed (required for 3-7 days)
Recovery and downtime
Immediate post-procedure (first week):
- Catheter: Required for 3-7 days (nearly all patients)
- Burning with urination (dysuria): Common – lasts 2-4 weeks
- Blood in urine (hematuria): Common – lasts 1-3 weeks
- Increased frequency/urgency: Temporary, improves over 4-8 weeks
Return to activities:
- Desk work: 3-7 days (after catheter removal)
- Physical labour: 2-4 weeks
- Exercise (light): 2 weeks
- Sexual activity: 3-4 weeks (after discomfort resolves)
Symptom improvement timeline:
- Weeks 1-2: Temporary worsening due to swelling (normal)
- Weeks 4-8: Initial symptom improvement begins
- Month 3: Significant improvement
- Month 6: Maximum benefit achieved
Effectiveness – symptom improvement and durability
Clinical studies demonstrate moderate outcomes with TUMT:
Clinical results:
- IPSS reduction: 40-50% (e.g., 22 → 12)
- Peak flow rate (Qmax) increase: 40-60% (e.g., 9 → 13-14 mL/s)
- Prostate size reduction: 20-40%
- Quality of life improvement: Moderate
Durability:
- 3-year data: Good symptom control
- 5-year data: Symptom improvement declines over time
- Re-treatment rate: 20-30% within 5 years (higher than Rezum or UroLift)
Patient satisfaction:
- 70-80% of men report being satisfied at 3-5 years
- Lower satisfaction compared to Rezum (85-90%) and UroLift (85-90%)
Side effects – retrograde ejaculation, dysuria, hematuria
TUMT has a moderate side effect profile:
Common side effects (occur in >10%):
- Urinary retention requiring catheter: 80-100% – nearly all patients need catheter for 3-7 days
- Dysuria (painful urination): 60-80% – lasts 2-4 weeks
- Hematuria (blood in urine): 50-70% – lasts 1-3 weeks
- Urinary frequency/urgency: 40-60% – temporary
- Retrograde ejaculation: 20-30%
Less common side effects (2-10%):
- Urinary tract infection: 5-10%
- Pelvic pain: 5-10%
- Urethral stricture: 2-5%
Rare side effects (<2%):
- Erectile dysfunction: 2-5% (higher than Rezum/UroLift)
- Urinary incontinence: <1%
- Rectal injury (very rare)
TUMT vs. TURP vs. Rezum vs. UroLift
| Feature | TUMT | Rezum | UroLift | TURP |
|---|---|---|---|---|
| Anaesthesia | Sedation | Local + sedation | Local | General/spinal |
| Procedure time | 30-60 min | 5-10 min | 15-30 min | 30-60 min |
| Catheter required | 80-100% (3-7 days) | 10-15% (1-3 days) | 5-10% | 100% (1-2 days) |
| Return to work | 1-2 weeks | 1-3 days | 1-3 days | 2-4 weeks |
| IPSS reduction | 40-50% | 50-60% | 40-50% | 60-70% |
| Retrograde ejaculation | 20-30% | 20-30% | <2% | 70-80% |
| Erectile dysfunction risk | 2-5% | <2% | <1% | 5-10% |
| 5-year re-treatment rate | 20-30% | 4-5% | 10-15% | <5% |
Cost and insurance coverage
- Medicare: Covers TUMT for eligible patients
- Private insurance: Most major insurers cover TUMT (coverage varies)
- Out-of-pocket cost: $2,000-$4,000 depending on insurance and facility fees
- Compared to other MISTs: TUMT is generally less expensive than Rezum or UroLift but has higher re-treatment rates
Why TUMT is less common today
Despite being a valid treatment option, TUMT has declined in popularity for several reasons:
- Slower recovery: Nearly all patients need a catheter for 3-7 days (vs. rare with UroLift)
- More discomfort: Dysuria and hematuria last longer (2-4 weeks vs. 1-2 weeks)
- Less durable: Higher re-treatment rates (20-30% at 5 years)
- Better alternatives: Rezum and UroLift offer faster recovery, fewer side effects, and better preservation of ejaculation
- Contraindications: Not suitable for men with pacemakers or metal implants
Interactive FAQ – TUMT procedure
During the procedure, sedation keeps you comfortable. Afterward, most men experience burning with urination (dysuria) for 2-4 weeks, which is managed with pain medication.
The procedure itself takes 30-60 minutes. Total time in the facility is about 2-4 hours.
Yes – nearly all men (80-100%) require a urinary catheter for 3-7 days after TUMT.
Yes – about 20-30% of men experience retrograde ejaculation after TUMT (similar to Rezum, higher than UroLift).
2-5% of men report new erectile dysfunction after TUMT – higher than Rezum (<2%) and UroLift (<1%).
IPSS improves by 40-50%. However, results are less durable than TURP, Rezum, or UroLift, with 20-30% needing re-treatment within 5 years.
Yes – if symptoms return, TUMT can be repeated. However, many men opt for TURP or a different MIST if initial TUMT fails.
Yes – Medicare and most private insurers cover TUMT. Check with your provider for specific coverage details.
No – for most patients, Rezum and UroLift offer faster recovery, fewer side effects, and better preservation of sexual function. TUMT is now less commonly performed.
Disclaimer: This information is for educational purposes. TUMT is a medical procedure with risks and benefits. Newer minimally invasive treatments (Rezum, UroLift) are often preferred. Discuss all options with a urologist at Vivekananda Hospital.